DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer

References

• van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084.
   PubMed Web of Science ®Google Scholar
• Omloo JMT, Lagarde SM, Hulscher JBF, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1001.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Donahue JM, Nichols FC, Li Z, et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg. 2009;87:392–399.
   PubMed Web of Science ®Google Scholar
• Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005;103:1347–1355.
   PubMed Web of Science ®Google Scholar
• Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol. 2005;23:4330–4337.
   PubMed Web of Science ®Google Scholar
• Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–1098.
   PubMed Web of Science ®Google Scholar
• Van Rossum PSN, Goense L, Meziani J, et al. Endoscopic biopsy and EUS for the detection of pathologic complete response after neoadjuvant chemoradiotherapy in esophageal cancer: a systematic review and meta-analysis. Gastrointest Endosc. 2016;83:866–879.
   PubMed Web of Science ®Google Scholar
• Westerterp M, van Westreenen HL, Reitsma JB, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy–systematic review. Radiology. 2005;236:841–851.
   PubMed Web of Science ®Google Scholar
• Kwee R. Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with Use of 18F FDG PET: a systematic review. Radiology. 2010;254:707–717.
   PubMed Web of Science ®Google Scholar
• Chen Y, Pan X, Tong L, et al. Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis. Nucl Med Commun. 2011;32:1005–1010.
   PubMed Web of Science ®Google Scholar
• Koh D, Collins DJ. Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology. Am J Roentgenol. 2007;188:1622–1635.
   PubMed Web of Science ®Google Scholar
• Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102–125.
   PubMed Web of Science ®Google Scholar
• Thoeny HC, Ross BD. Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging. 2010;32:2–16.
   PubMed Web of Science ®Google Scholar
• Bakke KM, Hole KH, Dueland S, et al. Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. Acta Oncol (Madr). 2017;56:813–818.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Hollingsworth KG, Sala E, et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63–74.
   PubMed Web of Science ®Google Scholar
• van Rossum PSN, van Lier ALHMW, van Vulpen M, et al. Diffusion-weighted magnetic resonance imaging for the prediction of pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer. Radiother Oncol. 2015;115:163–170.
   PubMed Web of Science ®Google Scholar
• Heethuis SE, van Rossum PSN, Lips IM, et al. Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy. Radiother Oncol. 2016;120:128–135.
   PubMed Web of Science ®Google Scholar
• Mandard A, Dalibard F, Mandard J. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73:2680–2686.
   PubMed Web of Science ®Google Scholar
• Jezzard P, Balaban RS. Correction for geometric distortion in echo planar images from B0 field variations. Magn Reson Med. 1995;34:65–73.
   PubMed Web of Science ®Google Scholar
• Fram EK, Herfkens RJ, Johnson GA, et al. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging. 1987;5:201–208.
   PubMed Web of Science ®Google Scholar
• Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31:1116–1128.
   PubMed Web of Science ®Google Scholar
• Bol GH, Kotte ANTJ, van der Heide UA, et al. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed. 2009;96:133–140.
   PubMed Web of Science ®Google Scholar
• Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716–723.
   Web of Science ®Google Scholar
• Lei J, Tian Y, Zhu S, et al. Preliminary study of IVIM-DWI and DCE-MRI in early diagnosis of esophageal cancer. Eur Rev Med Pharmacol Sci. 2015;19:3345–3350.
   PubMed Web of Science ®Google Scholar
• Li X, Abramson RG, Arlinghaus LR, et al. Combined DCE-MRI and DW-MRI for predicting breast cancer pathological response after the first cycle of neoadjuvant chemotherapy. Invest Radiol. 2015;50:195–204.
   PubMed Web of Science ®Google Scholar
• Chawla S, Kim S. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol. 2013;200:35–43.
   PubMed Web of Science ®Google Scholar
• Intven M, Monninkhof EM, Reerink O, et al. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer. Acta Oncol. 2015;54:1729–1736.
   PubMed Web of Science ®Google Scholar
• Weiss E, Ford JC, Olsen KM, et al. Apparent diffusion coefficient (ADC) change on repeated diffusion-weighted magnetic resonance imaging during radiochemotherapy for non-small cell lung cancer: a pilot study. Lung Cancer. 2016;96:113–119.
   PubMed Web of Science ®Google Scholar
• Habr-Gama A, Perez RO, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240:711–717-8.
   PubMed Web of Science ®Google Scholar
• Maas M, Beets-Tan RGH, Lambregts DMJ, et al. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol. 2011; 29:4633–4640.
   PubMed Web of Science ®Google Scholar
• El Naqa I, Bradley JD, Lindsay PE, et al. Predicting radiotherapy outcomes using statistical learning techniques. Phys Med Biol. 2009;54:S9–S30.
   PubMed Web of Science ®Google Scholar
• Oermann EK, Rubinsteyn A, Ding D, et al. Using a machine learning approach to predict outcomes after radiosurgery for cerebral arteriovenous malformations. Sci Rep. 2016;6:21161.
   PubMed Web of Science ®Google Scholar
• Shapiro J, Van Hagen P, Lingsma HF, et al. Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer. Ann Surg. 2014;260:807–814.
   PubMed Web of Science ®Google Scholar
• van der Werf LR, Dikken JL, van der Willik EM, et al. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: a nationwide study. Eur J Cancer. 2018;91:76–85.
   PubMed Web of Science ®Google Scholar